Hillsdale Investment Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,433
Closed -$541K 571
2021
Q4
$541K Hold
10,433
0.04% 374
2021
Q3
$623K Buy
+10,433
New +$656K 0.05% 346
2020
Q3
Sell
-58,199
Closed -$2.87M 598
2020
Q2
$2.87M Sell
58,199
-377
-0.6% -$20.3K 0.26% 116
2020
Q1
$2.98M Sell
58,576
-252
-0.4% -$14.5K 0.36% 74
2019
Q4
$3.24M Buy
58,828
+7,756
+15% +$421K 0.28% 127
2019
Q3
$2.57M Buy
51,072
+16,882
+49% +$848K 0.23% 131
2019
Q2
$1.72M Hold
34,190
0.17% 141
2019
Q1
$1.59M Hold
34,190
0.14% 141
2018
Q4
$1.68M Sell
34,190
-1,383
-4% -$78.7K 0.2% 122
2018
Q3
$2.21M Buy
35,573
+7,668
+27% +$466K 0.29% 52
2018
Q2
$1.5M Buy
+27,905
New +$1.39M 0.18% 98

Other funds holding EHC

Hillsdale Investment Management's EHC Position: Q1 2022 in Review

Hillsdale Investment Management sold out of Encompass Health (EHC) in Q1 2022, closing a stake of 10,433 shares — an estimated $541K sold.

Hillsdale Investment Management first reported a position in EHC in Q2 2018 and held it in 11 quarters. The position peaked at $3.24M in Q4 2019. 407 funds tracked by Wall St. Rank hold EHC as of Q1 2022.

  • Hillsdale Investment Management reported no remaining Encompass Health position as of Q1 2022 after selling out during the quarter.
  • Hillsdale Investment Management sold 10,433 Encompass Health shares in Q1 2022, an estimated $541K.
  • Hillsdale Investment Management first reported a position in Encompass Health in Q2 2018 and held it in 11 quarters.
  • Hillsdale Investment Management's Encompass Health position peaked at $3.24M in Q4 2019.
  • 407 funds tracked by Wall St. Rank held Encompass Health as of Q1 2022.

Based on Hillsdale Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.